Other
Target-Controlled Infusion
0
Pipeline Programs↗
4
Active Trials↗
0
Companies Involved↗
Target-controlled Infusion is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
19
clinical trials
Completed13 · 68%
Not yet recruiting2 · 11%
Unknown status2 · 11%
Active, not recruiting1 · 5%
Recruiting1 · 5%
Clinical Trials
Trial Activity
19 trials
Anesthesia Induction with the Target-controlled Infusion of Propofol in High-risk Patients
Recruiting·—·N/A·NCT06535230·200 enrolled
Target-controlled Infusion With Propofol in the Emergency Department : a Prospective Study on 45 Adult Patients
Completed·—·Phase 4·NCT03783494·45 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)